Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 562.013 - Applicability of Subchapter Unless a drug is determined to be generically equivalent to, or a biological product is determined to be interchangeable with, the brand prescribed, drug or biological product selection as authorized by this subchapter does not apply to:
(1) an enteric-coated tablet;(2) a controlled release product;(3) an injectable suspension, other than an antibiotic;(4) a suppository containing active ingredients for which systemic absorption is necessary for therapeutic activity; or(5) a different delivery system for aerosol or nebulizer drugs.Amended by Acts 2015, Texas Acts of the 84th Leg. - Regular Session, ch. 1007,Sec. 12, eff. 9/1/2015. Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. 9/1/1999.